Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endocrine therapy for a subset of older, frailer women with breast cancer. Choice of treatment is preference-sensitive and may require decision support. Older patients are often conceptualised as passive decision-makers. The present study used the Coping in Deliberation (CODE) framework to gain insight into decision making and coping processes in a group of older women who have faced breast cancer treatment decisions, and to inform the development of a decision support intervention (DSI). Methods: Semi-structured interviews were carried out with older women who had been offered a choice of PET or surgery from five UK hospital clinics. Women...
Around a third of breast cancers diagnosed each year in the UK are in women aged 70 years and older....
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast can...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Around a third of breast cancers diagnosed each year in the UK are in women aged 70 years and older....
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast can...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Around a third of breast cancers diagnosed each year in the UK are in women aged 70 years and older....
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...